Navigation Links
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
Date:9/9/2008

SAN DIEGO, Sept. 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that preclinical data will be presented on the Company's lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, at the American College of Gastroenterology Annual Scientific Meeting at the Gaylord Palms Resort & Convention Center in Orlando.
The presentation details are as follows:

Date/Time: Tuesday, October 7, 2008 from 10:30 a.m. - 4:00 p.m. EDT

Abstract Title: "RDEA119, a Potent and Highly Selective MEK1 / 2 Inhibitor

is Beneficial in Dextran Sulfate Sodium (DSS)-Induced

Chronic Colitis in Mice"

Poster Number: P1050

Session Title: Inflammatory Bowel Disease

Location: Florida Exhibit Halls

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of HIV, gout, cancer and inflammatory diseases. We have five product candidates in clinical trials and others in preclinical development and discovery. Our most advanced product candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which has successfully completed a Phase 2a study for the treatment of patients with HIV. We have evaluated our second-generation NNRTI for the treatment of HIV, RDEA427, in a human micro-dose pharmacokinetic study and have selected it for clinical development. RDEA594, our lead product candidate for the treatment of gout, is being evaluated in a Phase 1 clinical trial and is believed to be an inhibitor of the URAT1 transporter in the kidney, which is responsible for regulation of uric acid levels. We
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
2. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
3. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
4. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
5. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
6. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
9. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
10. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
11. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., Nov. 9 Women,s sexual health com...name to Viveve as it prepares for a 2010 launch of...ts. ,, "Viveve is a name that we believe captur...ual health," said Kerry Pope, Viveve,s president a...rpose of helping women restore their sense of fulf...
(Date:11/9/2009)...a., Nov. 9 LifeNet Health, a leadi...unch of Vertigraft Cervical Bio-Implant (VG2C) wit... is a new, proprietary glycerol-based preservation... stored in a fully hydrated state at ambient tempe...ze-dry bio-implants, doing away with lengthy thawi...
(Date:11/9/2009)...v. 9 RBC Life Sciences... proprietary nutritional supplements and wound car...the Top 100 workplaces in the Dallas-Fort Worth ar...the Top 100 Places to Work 2009 competition survey..., medium and large firms throughout the DFW metrop...
Breaking Medicine Technology:Women's Sexual Health Company Changes Name in Preparation for Market Entry 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area 2Bad Air Day Alert 3A Outdoor Air Pollutants at High Level 54653 1Bad Air Day Alert 3A Outdoor Air Pollutants at High Level 54653 2Bad Air Day Alert 3A Outdoor Air Pollutants at High Level 54653 3Cancers break in tools possibly identified at Duke 54650 1Cancers break in tools possibly identified at Duke 54650 2Taking up music so you can hear 54647 1Taking up music so you can hear 54647 2Taking up music so you can hear 54647 3
(Date:11/9/2009)...ed with new cells regained sexual function, study ...ews) -- Researchers were able to restore sexual fu...new penile tissue in the lab and implanting it, a ... is a ways off, researchers say the technique coul...tion in men. , "We were able to show the tissue...
(Date:11/9/2009)... Tomorrow may be too late when it comes ...ccording to TOPS Club, Inc. (Take Off Pounds Sensi...on. , (Vocus) November 9,... preventing or improving a diabetes condition, acc...y), the nonprofit weight-loss support organization...
(Date:11/9/2009)...ICA, Calif., Nov. 9 Actress Marisk...ned philosophy on Saturday to raise awareness ...ces throughout California by building healing and ...h kits were created to give one to each of the est...Los Angeles County,s domestic violence shelters. ,...
(Date:11/9/2009)...Nov. 9 For the third co...nter has been selected the most preferred hospital...to a survey by the National Research Corporation. ...h/20071106/KARMANOSLOGO ) ,, The annual survey...een September 2008 and August 2009. Survey respond...
(Date:11/9/2009)... Nov. 9 /PRNewswire/ -- Phoenix House , the n...treatment and prevention program, announced today ...y and internationally recognized leader in substan... Officer, effective January 1, 2010. ,, "Dr. ...abuse treatment research and her work has resulted...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
..., Ind., Sept. 27 Conseco, Inc. (NYSE:,CNO) will h... care business,at 3:00 p.m. Eastern Daylight Time ...nce call earlier today, a technical problem at a s...70 and use the,Conference ID 18906493. The presen...
...IA, Md., Sept. 27 Martek Biosciences, a,DHA omega...has introduced,under the Bellybar(TM) brand, new a...M), Martek,s patented, vegetarian form of DHA omeg...50 mg per bar of life,sDHA(TM), a fatty acid impor...
...T NEWS, Va., Sept. 27 The Patient,Advocate Founda...hat,provides patient services to tens of thousands...ccess to care because of financial or insurance,de...amthun; Pearl Moore, RN; Alan Balch, PhD; and Venu...
...ng members to search areas of expertise and other ...herapist, EDEN PRAIRIE, Minn., Sept. 27 CIGNA Be... online provider profiles that offer a,photograph ... experience. Available at http://www.cignabehavio...
...a is leading cause of parasitic infections in U.S...sts have sequenced the genome of the intestinal pa...n 20,000 reported infections a year in the United ...act Giardia through contact with infected stool or...
... ARBOR, Mich. People who have the common chronic ... dont respond to the types of medication that reli...ersity of Michigan Health System helps to explain ...id painkiller drugs such as morphine. , The study...
Other Medicine News:Health News:Martek Announces Addition of life'sDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars 2Health News:Martek Announces Addition of life'sDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars 3Health News:Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors 2Health News:Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors 3Health News:CIGNA Behavioral Health Offers Members Online Provider Profiles 2Health News:Scientists Map Intestinal Bug's Genome 2Health News:Why don't painkillers work for people with fibromyalgia? 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: